OptiNose, Inc.: Financial Report Reveals Stability
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
- Latest
- Trending
OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...
Researchers at KIT's Institute for Advanced Membrane Technology (IAMT) have developed nanotubes with small pores that have a highly adsorbing ...
Australian man arrested in connection with largest drug ring in ACT history. Charges include trafficking, fraud, and supplying anabolic steroids. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.